EEG characteristics of dementia with Lewy bodies, Alzheimer's disease and mixed pathology
JJ Van der Zande, AA Gouw… - Frontiers in aging …, 2018 - frontiersin.org
Frontiers in aging neuroscience, 2018•frontiersin.org
Introduction: Previous studies on electroencephalography (EEG) to discriminate between
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) have been promising.
These studies did not consider the pathological overlap of the two diseases. DLB-patients
with concomitant AD pathology (DLB/AD+) have a more severe disease manifestation. The
EEG may also be influenced by a synergistic effect of the two pathologies. We aimed to
compare EEG characteristics between DLB/AD+,“pure” DLB (DLB/AD−) and AD. Methods …
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) have been promising.
These studies did not consider the pathological overlap of the two diseases. DLB-patients
with concomitant AD pathology (DLB/AD+) have a more severe disease manifestation. The
EEG may also be influenced by a synergistic effect of the two pathologies. We aimed to
compare EEG characteristics between DLB/AD+,“pure” DLB (DLB/AD−) and AD. Methods …
Introduction: Previous studies on electroencephalography (EEG) to discriminate between dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD) have been promising. These studies did not consider the pathological overlap of the two diseases. DLB-patients with concomitant AD pathology (DLB/AD+) have a more severe disease manifestation. The EEG may also be influenced by a synergistic effect of the two pathologies. We aimed to compare EEG characteristics between DLB/AD+, “pure” DLB (DLB/AD−) and AD.
Methods: We selected probable DLB patients who had an EEG and cerebrospinal fluid (CSF) available, from the Amsterdam Dementia Cohort (ADC). Concomitant AD-pathology was defined as a CSF tau/Aβ-42 ratio > 0.52. Forty-one DLB/AD+ cases were matched for age (mean 70 (range 53–85)) and sex (85% male) 1:1 to DLB/AD− and AD-patients. EEGs were assessed visually, with Fast Fourier Transform (FFT), network- and connectivity measures.
Results: EEG visual severity score (range 1–5) did not differ between DLB/AD− and DLB/AD+ (2.7 in both groups) and was higher compared to AD (1.9, p < 0.01). Both DLB groups had a lower peak frequency (7.0 Hz and 6.9 Hz in DLB vs. 8.2 in AD, p < 0.05), more slow-wave activity and more prominent disruptions of connectivity and networks, compared to AD. No significant differences were found between DLB/AD+ and DLB/AD−.
Discussion: EEG abnormalities are more pronounced in DLB, regardless of AD co-pathology. This emphasizes the valuable role of EEG in discriminating between DLB and AD. It suggests that EEG slowing in DLB is influenced more by the α-synucleinopathy, or the associated cholinergic deficit, than by amyloid and tau pathology.
Frontiers以上显示的是最相近的搜索结果。 查看全部搜索结果